Screener
Dianthus Therapeutics DNTH Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Dianthus Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The source filing: Dianthus Therapeutics’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001690585-26-000022
FAQ
- What is Dianthus Therapeutics's net income?
- Dianthus Therapeutics (DNTH) reported net income of -$40.83M in Q1 2026.
- How has Dianthus Therapeutics's net income changed year-over-year?
- Dianthus Therapeutics's net income decreased by 38.4% year-over-year, from -$29.51M to -$40.83M.
- What is the long-term trend for Dianthus Therapeutics's net income?
- Over 3 years (2021 to 2024), Dianthus Therapeutics's net income has grown at a 6.1% compound annual growth rate (CAGR), from -$71.14M to -$84.97M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.
Ask your AI about Dianthus Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude